Bombay High Court: ‘GIRNAR’ a Well Known Trademark in India  ||  Kerala HC: Criminal Courts of District Judiciary Cannot Recall their Earlier Orders  ||  Madras HC: Only ‘Preponderance of Probability’ Required in Disciplinary Proceedings  ||  Raj HC: Non-Disclosure of Information Wasn’t a Ground for Disqualification Before 2015 Amendment Act  ||  Bom. HC: Workers in Statutory Canteens are Principal Employer’s Employees  ||  Supreme Court: NCLAT Cannot Use its ‘Inherent Powers’ to Subvert Legal Provisions  ||  Supreme Court: NCLAT Cannot Use its ‘Inherent Powers’ to Subvert Legal Provisions  ||  SC Refuses to Mark Presence of Advocate Who Did Not Argue the Matter  ||  SC Sets Aside HC’s Decision to Accept Aadhaar Card as a Proof of Date of Birth  ||  SC Permits Candidate with Blindness to Attend Interview for Selection of Civil Judges in Rajasthan    

Search Results for Tag : Natco Pharma

News

Delhi High Court Awards Natco Pharma Interim Relief in BMS Patents Case(23.07.2019)

Delhi High Court has awarded interim relief to the Hyderabad-based Natco Pharma Ltd in a fresh patents battle, with the court setting aside an injunc.....

Tags : Delhi High Court, Natco Pharma



Natco Settles Patent Dispute with Gilead in a US Court(15.12.2015)

Natco Pharma along with its partner Alvogen has settled the patent infringement suit with Gilead Sciences Inc. and others over “Tamiflu” in a US court.....

Tags : Natco Pharma , Alvogen, Tamiflu, Patent Dispute



U.S. PTO Rules in Favour of Mylan(29.08.2016)

U.S.Patent and Trademark Office (PTO) has ruled in the favour of Natco Pharma’s marketing partner Mylan, with regard to patent claims pertaining to mu.....

Tags : U.S.Patent and Trademark Office, Natco Pharma, patent claims



Celgene Settles Revlimid Patent Dispute with Natco Pharma(24.12.2015)

Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s c.....

Tags : Natco Pharma, Celgene Corp, Revlimid Patent



Disclaimer | Copyright 2024 - All Rights Reserved